Core Points - A shareholder class action lawsuit has been filed against Lifecore Biomedical, Inc. alleging that the company made materially false and misleading statements regarding its business and operations [3] - The lawsuit claims that Lifecore had deficient internal controls over financial reporting, leading to inaccurate financial statements that would need to be restated [3] - It is alleged that Lifecore's remediation efforts regarding these deficiencies were ineffective, impairing the company's ability to file periodic reports with the SEC in compliance with NASDAQ requirements [3] - The lawsuit asserts that Lifecore's financial position and prospects were materially overstated as a result of these issues [3] - The deadline for shareholders to request to be appointed as lead plaintiff in the case is September 27, 2024 [4]
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm